KEVIN OSTRANDER, MS, MBA
Chief Business Officer
Kevin has 30+ years of experience in the pharmaceutical industry, having worked in various capacities for BioDelivery Sciences, Glenmark Pharmaceuticals, Sandoz, Mylan, Watson Pharmaceuticals and Elan Drug Delivery.
For the past 20+ years, Kevin has been a leading business development executive, assisting in overall corporate revenue growth through select product/technology partnerships. He has completed 75 transactions with a total value exceeding $1.5 billion.
Kevin holds a BS degree in Biology from SUNY Albany, an MS degree in Pharmaceutical Quality Assurance and Regulatory Affairs from Temple University School of Pharmacy and an MBA in International Business from St. Joseph’s University.
Mission
An innovative drug is one thing. An innovative delivery system that lets millions more benefit from it is another.
Heritage
A legacy of delivering firsts.
Technologies
Pioneering penetrating breakthroughs.
Manufacturing
Cutting-edge technologies demand cutting-edge production.
Partnerships
Game-changing delivery platforms lead to game-changing products.